CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Pilot Study of Pembrolizumab and Liver-Directed Therapy or Peptide Receptor Radionuclide Therapy for Patients With Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03457948
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-08-29T00:04:38.739816+00:00
Published At: 2026-08-28T00:00:00+00:00
Record Updated At: 2026-08-28
Results Posted At: 2026-08-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Malignant Neoplasm in the Liver", "Neuroendocrine Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-08-28"
protocolSection.identificationModule.nctId: "NCT03457948"
protocolSection.identificationModule.officialTitle: "A Pilot Study of Pembrolizumab and Liver-Directed Therapy or Peptide Receptor Radionuclide Therapy for Patients With Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-08-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.